Torrent Pharmaceuticals Limited (BOM:500420)
India flag India · Delayed Price · Currency is INR
5,102.80
+232.15 (4.77%)
At close: Jul 31, 2026

Torrent Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-11,1725,7358,3515,0853,984
Short-Term Investments
-3,72322.8279581.65.9
Trading Asset Securities
-8,6571,1221,4101,5611,840
Cash & Short-Term Investments
23,55223,5526,88010,0407,2285,830
Cash Growth
242.34%242.34%-31.48%38.91%23.98%-21.01%
Accounts Receivable
-30,30918,66518,44319,43816,325
Other Receivables
-6,4853,7733,3902,8442,786
Receivables
-36,84622,48021,86322,30019,137
Inventory
-31,38225,41322,79122,29624,623
Prepaid Expenses
-981.3631.1589.5666.9514.6
Restricted Cash
-152.649.338.64844.4
Other Current Assets
-1,017773.4793753.32,798
Total Current Assets
-93,93156,22656,11553,29252,947
Property, Plant & Equipment
-53,66038,22935,77834,59832,469
Long-Term Investments
-994.1445.7332.9711.1679.2
Goodwill
-39,8963,3893,3803,3752,595
Other Intangible Assets
-244,63642,63345,82850,89535,461
Long-Term Deferred Tax Assets
-6,9835,9425,5515,4374,937
Other Long-Term Assets
-2,9863,0003,5961,7851,894
Total Assets
-443,120149,897150,606150,119130,998

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-23,57618,20020,89316,78816,744
Accrued Expenses
-7,0564,1743,7843,6903,111
Short-Term Debt
-29,14612,97316,55118,1139,620
Current Portion of Long-Term Debt
-2,3255,8446,95910,3609,718
Current Portion of Leases
-371.9303.7200.6183.3147.3
Current Income Taxes Payable
-1,209955.71,679313.1414.8
Current Unearned Revenue
-281.924.45018.3114.8
Other Current Liabilities
-19,4684,6984,1345,0074,280
Total Current Liabilities
-83,43347,17254,25354,47344,151
Long-Term Debt
-116,51211,91816,03824,96221,232
Long-Term Leases
-1,9011,459644.6529.3368.2
Long-Term Unearned Revenue
-2244.69.614.619.6
Pension & Post-Retirement Benefits
-936.3813.2836788.1897.5
Long-Term Deferred Tax Liabilities
-56,7008,2876,5614,0191,936
Other Long-Term Liabilities
-7,5654,3383,7033,3512,865
Total Liabilities
-267,27173,99182,04488,13871,469

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-1,6921,6921,6921,692846.2
Additional Paid-In Capital
-----43.4
Retained Earnings
-86,43976,30767,90861,15957,739
Comprehensive Income & Other
--4,247-2,092-1,039-870.5900.6
Total Common Equity
83,88483,88475,90768,56261,98159,530
Minority Interest
-91,964----
Shareholders' Equity
175,848175,84875,90768,56261,98159,530
Total Liabilities & Equity
-443,120149,897150,606150,119130,998

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
150,255150,25532,49640,39454,14841,086
Net Cash (Debt)
-126,703-126,703-25,616-30,354-46,921-35,257
Net Cash Growth
------
Net Cash Per Share
-363.06-374.37-75.69-89.69-138.64-104.17
Filing Date Shares Outstanding
380.63338.45338.45338.45338.45338.45
Total Common Shares Outstanding
380.63338.45338.45338.45338.45338.45
Working Capital
-10,4989,0541,862-1,1818,796
Book Value Per Share
247.85247.85224.28202.58183.13175.89
Tangible Book Value
-200,648-200,64829,88619,3537,71121,474
Tangible Book Value Per Share
-592.85-592.8588.3057.1822.7863.45
Land
-7,1886,8086,8046,6256,953
Buildings
-21,66415,78514,91011,34311,698
Machinery
-37,61730,95129,16825,81925,792
Construction In Progress
-4,5753,6732,8086,8825,443